Flagship Harbor Advisors LLC cut its holdings in shares of Abrdn Life Sciences Investors (NYSE:HQL - Free Report) by 20.0% in the 4th quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission. The firm owned 250,441 shares of the company's stock after selling 62,502 shares during the period. Flagship Harbor Advisors LLC owned approximately 0.92% of Abrdn Life Sciences Investors worth $3,286,000 at the end of the most recent reporting period.
A number of other institutional investors and hedge funds have also added to or reduced their stakes in the business. Future Financial Wealth Managment LLC bought a new position in shares of Abrdn Life Sciences Investors in the third quarter valued at approximately $30,000. Sanctuary Advisors LLC lifted its position in Abrdn Life Sciences Investors by 11.4% in the third quarter. Sanctuary Advisors LLC now owns 13,256 shares of the company's stock worth $183,000 after purchasing an additional 1,355 shares during the period. Penserra Capital Management LLC bought a new position in Abrdn Life Sciences Investors during the 3rd quarter valued at $11,702,000. International Assets Investment Management LLC bought a new position in Abrdn Life Sciences Investors during the 3rd quarter valued at $204,000. Finally, Stephens Inc. AR increased its position in shares of Abrdn Life Sciences Investors by 7.6% during the 3rd quarter. Stephens Inc. AR now owns 12,707 shares of the company's stock valued at $192,000 after purchasing an additional 896 shares during the period. 32.21% of the stock is owned by institutional investors.
Abrdn Life Sciences Investors Trading Up 0.8 %
Shares of Abrdn Life Sciences Investors stock traded up $0.12 during trading on Friday, hitting $14.07. The stock had a trading volume of 117,709 shares, compared to its average volume of 121,507. The business has a fifty day moving average of $13.76 and a two-hundred day moving average of $14.63. Abrdn Life Sciences Investors has a fifty-two week low of $12.76 and a fifty-two week high of $15.90.
Abrdn Life Sciences Investors Increases Dividend
The firm also recently declared a quarterly dividend, which was paid on Friday, January 10th. Shareholders of record on Thursday, November 21st were issued a $0.50 dividend. This represents a $2.00 dividend on an annualized basis and a yield of 14.22%. This is an increase from Abrdn Life Sciences Investors's previous quarterly dividend of $0.49. The ex-dividend date was Thursday, November 21st.
About Abrdn Life Sciences Investors
(
Free Report)
Abrdn Life Sciences Investors is a closed-ended equity mutual fund launched and managed by abrdn Inc The fund invests in public equity markets across the globe. It seeks to invest in stocks of companies operating in the life sciences sector, including the biotechnology, pharmaceutical, diagnostics, managed healthcare, medical equipment, hospitals, healthcare information technology and services, devices and supplies industries, and in agriculture and environmental management industries.
Further Reading

Before you consider Abrdn Life Sciences Investors, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Abrdn Life Sciences Investors wasn't on the list.
While Abrdn Life Sciences Investors currently has a "Hold" rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Looking to profit from the electric vehicle mega-trend? Enter your email address and we'll send you our list of which EV stocks show the most long-term potential.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.